Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Which product categories are most exposed to declining demand
The Dual Amylin- and Calcitonin Receptor Agonist KBP-042 Works as Adjunct to Metformin on Fasting Hyperglycemia and HbA1c in a Rat Model of Type 2 Diabetes
Dr Alan Moses, Novo's Senior VP, Global Chief Medical Officer was in London last week to showcase the company's pipeline, and told pharmaphorum that the firm is planning for decades of further drug development against the killer epidemic
She likens the phenomenon to insulin resistance, which is still not fully understood decades after its discovery
US$ 24.45
US$ 24.05
US$ 23.32
US$ 24.96
